Cardiac Rhythm Management Devices – Medical Devices Pipeline Assessment, 2020

Cardiac Rhythm Management (CRM) devices are those devices which are used to restore the natural synchronized pumping rhythm of the heart. GlobalData's Medical Devices sector report, “Cardiac Rhythm Management Devices – Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Cardiac Rhythm Management Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Cardiac Rhythm Management Devices Pipeline Assessment report provides key information and data related to:

Extensive coverage of the Cardiac Rhythm Management Devices under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Cardiac Rhythm Management Devices pipeline products.

Review of Recent Developments in the segment / industry

The Cardiac Rhythm Management Devices Pipeline Assessment report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Glaucoma Drainage Device sunder development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

The major companies covered in the “Cardiac Rhythm Management Devices- Medical Devices Pipeline Assessment, 2020” report:

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports

• 64,000+ medical equipment company profiles

• 5,600+ company profiles of medical equipment manufacturers in China and India

• 2,200+ company profiles of medical equipment manufacturers in Japan

• 1,200+ companies’ revenue splits and market shares

• 1,600+ quarterly and annual medical equipment company financials

• 850+ medical equipment company SWOTs

• 28,000+ pipeline product profiles

• 56,400+ marketed product profiles

• 47,000+ clinical trials

• 41,500+ trial investigators

• 7,000+ reports on companies with products in development

• 44,000+ deals in the medical equipment industry

• 1,100+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

• 431,000+ Themes Content Items

• 600+ Influencers

• 1,900+ Analysts & Researchers

• 0.5m+ Community Members

• 141,000+ Macroeconomic Indicators

• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Cardiac Rhythm Management Devices under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Cardiac Rhythm Management Devices and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of Cardiac Rhythm Management Devices under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies mentioned

A3 Remote Monitoring Technologies Pvt Ltd

Advanced BioInformatics GmbH

AIS Inc.

Angel Medical Systems Inc

Arizona State University

AtaCor Medical Inc

Bionet Sonar Inc

Biotronik SE & Co KG

Boston Scientific Corp

Boston TransTec LLC

Cairdac

CardiaLen, Inc.

Cardioalarm, Inc

Children’s National Health System

Corhythm Inc

Coridea, LLC

CVRx Inc

DHS Medical

Drexel University

Duke University

EBR Systems Inc

Endurance Rhythm Inc.

Hadassah Medical Center

Impulse Dynamics NV

InnerPulse Inc (Inactive)

Integer Holdings Corp

IRadimed Corp

Johns Hopkins University

Kenergy Inc.

Kestra Medical Technologies Inc

Krisara Engineering, LLC

Massachusetts General Hospital

Max Planck Institute for Dynamics and Self-Organization

Mayo Clinic

Medicool Technologies Inc

Medtronic Plc

MicroPort CRM

MicroPort Scientific Corp

NanoLinea

NewPace Ltd

NuVascular Technologies Inc

Odem Medical Ltd

Ohio State University

Osypka Medical GmbH

Perpetuum Ltd

Queen Mary University of London

Rice University

Shaanxi Qinming Medical Instruments Co Ltd

Smartwave Medical Ltd (Inactive)

Spectranetics Corp

St. Jude Medical LLC

SUNY Downstate Medical Center

Suzhou Wushuang Medical Equipment Co Ltd

Teleflex Inc

Thayer School of Engineering at Dartmouth

U.S. Stem Cell Inc

University of Bern

University of California Los Angeles

University of Glasgow

University of Michigan

University of Southern California

University of Utah

Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 13

2 Introduction 14

2.1 Cardiac Rhythm Management Devices Overview 14

3 Products under Development 16

3.1 Cardiac Rhythm Management Devices – Pipeline Products by Stage of Development 16

3.2 Cardiac Rhythm Management Devices – Pipeline Products by Segment 17

3.3 Cardiac Rhythm Management Devices – Pipeline Products by Territory 18

3.4 Cardiac Rhythm Management Devices – Pipeline Products by Regulatory Path 19

3.5 Cardiac Rhythm Management Devices – Pipeline Products by Estimated Approval Date 20

3.6 Cardiac Rhythm Management Devices – Ongoing Clinical Trials 21

4 Cardiac Rhythm Management Devices – Pipeline Products under Development by Companies 22

4.1 Cardiac Rhythm Management Devices Companies – Pipeline Products by Stage of Development 22

4.2 Cardiac Rhythm Management Devices – Pipeline Products by Stage of Development 25

5 Cardiac Rhythm Management Devices Companies and Product Overview 28

5.1 A3 Remote Monitoring Technologies Pvt Ltd Company Overview 28

5.1.1 A3 Remote Monitoring Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 28

5.2 Advanced BioInformatics GmbH Company Overview 29

5.2.1 Advanced BioInformatics GmbH Pipeline Products & Ongoing Clinical Trials Overview 29

5.3 AIS Inc. Company Overview 30

5.3.1 AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview 30

5.4 Angel Medical Systems Inc Company Overview 31

5.4.1 Angel Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 31

5.5 Arizona State University Company Overview 32

5.5.1 Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 32

5.6 AtaCor Medical Inc Company Overview 33

5.6.1 AtaCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 33

5.7 Bionet Sonar Inc Company Overview 36

5.7.1 Bionet Sonar Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.8 Biotronik SE & Co KG Company Overview 37

5.8.1 Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview 37

5.9 Boston Scientific Corp Company Overview 40

5.9.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 40

5.10 Boston TransTec LLC Company Overview 55

5.10.1 Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview 55

5.11 Cairdac Company Overview 56

5.11.1 Cairdac Pipeline Products & Ongoing Clinical Trials Overview 56

5.12 CardiaLen, Inc. Company Overview 57

5.12.1 CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57

5.13 Cardioalarm, Inc Company Overview 60

5.13.1 Cardioalarm, Inc Pipeline Products & Ongoing Clinical Trials Overview 60

5.14 Children’s National Health System Company Overview 61

5.14.1 Children’s National Health System Pipeline Products & Ongoing Clinical Trials Overview 61

5.15 Corhythm Inc Company Overview 62

5.15.1 Corhythm Inc Pipeline Products & Ongoing Clinical Trials Overview 62

5.16 Coridea, LLC Company Overview 63

5.16.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview 63

5.17 CVRx Inc Company Overview 64

5.17.1 CVRx Inc Pipeline Products & Ongoing Clinical Trials Overview 64

5.18 DHS Medical Company Overview 69

5.18.1 DHS Medical Pipeline Products & Ongoing Clinical Trials Overview 69

5.19 Drexel University Company Overview 71

5.19.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 71

5.20 Duke University Company Overview 72

5.20.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 72

5.21 EBR Systems Inc Company Overview 73

5.21.1 EBR Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 73

5.22 Endurance Rhythm Inc. Company Overview 77

5.22.1 Endurance Rhythm Inc. Pipeline Products & Ongoing Clinical Trials Overview 77

5.23 Hadassah Medical Center Company Overview 78

5.23.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 78

5.24 Impulse Dynamics NV Company Overview 79

5.24.1 Impulse Dynamics NV Pipeline Products & Ongoing Clinical Trials Overview 79

5.25 InnerPulse Inc (Inactive) Company Overview 80

5.25.1 InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 80

5.26 Integer Holdings Corp Company Overview 82

5.26.1 Integer Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 82

5.27 IRadimed Corp Company Overview 84

5.27.1 IRadimed Corp Pipeline Products & Ongoing Clinical Trials Overview 84

5.28 Johns Hopkins University Company Overview 85

5.28.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 85

5.29 Kenergy Inc. Company Overview 89

5.29.1 Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview 89

5.30 Kestra Medical Technologies Inc Company Overview 91

5.30.1 Kestra Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 91

5.31 Krisara Engineering, LLC Company Overview 92

5.31.1 Krisara Engineering, LLC Pipeline Products & Ongoing Clinical Trials Overview 92

5.32 Massachusetts General Hospital Company Overview 93

5.32.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 93

5.33 Max Planck Institute for Dynamics and Self-Organization Company Overview 95

5.33.1 Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview 95

5.34 Mayo Clinic Company Overview 96

5.34.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 96

5.35 Medicool Technologies Inc Company Overview 99

5.35.1 Medicool Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 99

5.36 Medtronic Plc Company Overview 100

5.36.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 100

5.37 MicroPort CRM Company Overview 113

5.37.1 MicroPort CRM Pipeline Products & Ongoing Clinical Trials Overview 113

5.38 MicroPort Scientific Corp Company Overview 127

5.38.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 127

5.39 NanoLinea Company Overview 131

5.39.1 NanoLinea Pipeline Products & Ongoing Clinical Trials Overview 131

5.40 NewPace Ltd Company Overview 132

5.40.1 NewPace Ltd Pipeline Products & Ongoing Clinical Trials Overview 132

5.41 NuVascular Technologies Inc Company Overview 133

5.41.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 133

5.42 Odem Medical Ltd Company Overview 134

5.42.1 Odem Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 134

5.43 Ohio State University Company Overview 136

5.43.1 Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 136

5.44 Osypka Medical GmbH Company Overview 137

5.44.1 Osypka Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 137

5.45 Perpetuum Ltd Company Overview 139

5.45.1 Perpetuum Ltd Pipeline Products & Ongoing Clinical Trials Overview 139

5.46 Queen Mary University of London Company Overview 140

5.46.1 Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview 140

5.47 Rice University Company Overview 141

5.47.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 141

5.48 Shaanxi Qinming Medical Instruments Co Ltd Company Overview 143

5.48.1 Shaanxi Qinming Medical Instruments Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 143

5.49 Smartwave Medical Ltd (Inactive) Company Overview 144

5.49.1 Smartwave Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 144

5.50 Spectranetics Corp Company Overview 145

5.50.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview 145

5.51 St. Jude Medical LLC Company Overview 146

5.51.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 146

5.52 SUNY Downstate Medical Center Company Overview 150

5.52.1 SUNY Downstate Medical Center Pipeline Products & Ongoing Clinical Trials Overview 150

5.53 Suzhou Wushuang Medical Equipment Co Ltd Company Overview 151

5.53.1 Suzhou Wushuang Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 151

5.54 Teleflex Inc Company Overview 152

5.54.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 152

5.55 Thayer School of Engineering at Dartmouth Company Overview 153

5.55.1 Thayer School of Engineering at Dartmouth Pipeline Products & Ongoing Clinical Trials Overview 153

5.56 U.S. Stem Cell Inc Company Overview 154

5.56.1 U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview 154

5.57 University of Bern Company Overview 155

5.57.1 University of Bern Pipeline Products & Ongoing Clinical Trials Overview 155

5.58 University of California Los Angeles Company Overview 156

5.58.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 156

5.59 University of Glasgow Company Overview 158

5.59.1 University of Glasgow Pipeline Products & Ongoing Clinical Trials Overview 158

5.60 University of Michigan Company Overview 159

5.60.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 159

5.61 University of Southern California Company Overview 160

5.61.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 160

5.62 University of Utah Company Overview 162

5.62.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview 162

6 Cardiac Rhythm Management Devices- Recent Developments 163

6.1 Jul 08, 2020: CVRx raises fresh funds to support commercialisation of BAROSTIM NEO 163

6.2 Jun 25, 2020: Integer Opens New Innovative Ireland Research and Development Facility 163

6.3 Jun 15, 2020: MicroPort announces strategic investment and forms joint venture with Indian medical device company purple medical 164

6.4 Jun 04, 2020: Vital Defibrillator donated to first responders 165

6.5 May 15, 2020: Microport orthopedics group brings in new strategic investors 165

6.6 May 08, 2020: First Direct Comparison of ICD Devices Underscores Benefits of the S-ICD with Better Safety Profile and Fewer Device-Related Complications 166

6.7 Apr 24, 2020: FDA lifts injunction on manufacture and distribution of Philips’ defibrillators in the US 167

6.8 Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific 168

6.9 Feb 27, 2020: Philips and the European Society of Radiology to host Ultrasound Academy at ECR 2020 169

6.10 Feb 26, 2020: LivaNova reports fourth quarter and full-year 2019 results 169

6.11 Feb 26, 2020: Mayo Clinic reports 'remarkable growth' in 2019 171

6.12 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer 171

6.13 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer 172

6.14 Feb 21, 2020: World’s tiniest pacemaker coordinates heartbeats from top to bottom 173

6.15 Feb 20, 2020: Integer acquires Israel-based medical device firm Inomec 174

6.16 Feb 20, 2020: Integer Holdings reports results for fourth quarter and full year 2019 175

6.17 Feb 19, 2020: Abbott receives CE mark for heart rhythm management devices 176

6.18 Feb 18, 2020: Medtronic reports third quarter financial results 2020 177

6.19 Feb 12, 2020: ClearPoint Neuro reports 53% increase in 2019 revenue 179

6.20 Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year 2019 181

6.21 Feb 05, 2020: Surmodics reports first quarter Fiscal 2020 results 182

6.22 Feb 03, 2020: Hackensack University Medical Center first hospital in nation to implant world's first heart failure neuromodulation device 183

6.23 Feb 03, 2020: Surmodics names Nusrath Sultana, MD, as Vice President, Clinical Affairs 184

6.24 Jan 28, 2020: BIOTRONIK launches next generation injectable cardiac monitor in Japan 185

6.25 Jan 28, 2020: Philips' fourth quarter and annual results 2019 185

6.26 Jan 21, 2020: FDA approves Medtronic Micra AV, the world’s smallest pacemaker which can now treat AV block 189

6.27 Jan 14, 2020: Implantable cardiac monitors detect atrial fibrillation after stroke of unknown cause recommended for routine NHS adoption 190

6.28 Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2019 191

6.29 Jan 13, 2020: T2 Biosystems promotes Tony Pare to Chief Commercial Officer 192

6.30 Jan 13, 2020: MRI Interventions to change corporate name to ClearPoint Neuro 193

6.31 Jan 10, 2020: Insertable monitors shown to detect atrial fibrillation more reliably than short-term strategies 193

6.32 Jan 09, 2020: T2 Biosystems announces preliminary fourth quarter 2019 financial results 195

6.33 Jan 09, 2020: T2 Biosystems appoints industry veteran John Sperzel as chief executive officer 195

6.34 Jan 06, 2020: Philips expands its range of consumer-focused digital health solutions at CES 2020 196

6.35 Dec 23, 2019: iRhythm Technologies files quarterly report on form 10-Q for third quarter 2019 and updates guidance for full year 2019 198

6.36 Dec 23, 2019: Mayo Clinic names chief digital officer to lead transformative digital strategy, create Center for Digital Health 198

6.37 Dec 17, 2019: Philips to nominate Feike Sijbesma and Peter Löscher as members of the Supervisory Board 199

6.38 Dec 16, 2019: Developing next-generation biologic pacemakers 200

6.39 Dec 11, 2019: Innovation Hub provides funding to seven entrepreneurial teams 200

6.40 Dec 05, 2019: Orthofix names Kevin Kenny president of global spine business 203

6.41 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe 204

6.42 Dec 03, 2019: Dr. John Halamka named president of Mayo Clinic Platform 204

6.43 Dec 02, 2019: Concord Medical announces changes to the Board 205

6.44 Nov 22, 2019: Stereotaxis CEO to present at the 12th Annual BIOMEDevice San Jose Conference 205

6.45 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 206

6.46 Nov 19, 2019: FDA-approved devices that help Keep the heart beating 208

6.47 Nov 18, 2019: Integer updates 2019 guidance following customer chapter 11 filing, no change in prior view of 2020 sales outlook 209

6.48 Nov 14, 2019: Stereotaxis reports 2019 third quarter financial results 210

6.49 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 211

6.50 Nov 12, 2019: T2 Biosystems reports third quarter 2019 financial highlights and provides corporate update 212

6.51 Nov 12, 2019: MRI Interventions reports 62% increase in 2019 third quarter revenue 213

6.52 Nov 12, 2019: Integer announces commitments to reprice and extend maturity of its revolving credit facility and term Loan A; launches term Loan B repricing 215

6.53 Nov 12, 2019: Cardiac Resynchronization therapy benefits cancer survivors with heart failure 215

6.54 Nov 11, 2019: New study shows promise in treating more patients with world’s smallest pacemaker 218

6.55 Nov 08, 2019: Texas Heart Institute’s Research Team receives prestigious federal grant to develop a wireless and leadless Pacemaker System 219

6.56 Nov 05, 2019: Impulse Dynamics secures Transitional Pass-through (TPT) incremental payment for the Optimizer Smart System 221

6.57 Nov 05, 2019: iRhythm Technologies announces third quarter 2019 financial results 222

6.58 Nov 04, 2019: Ventripoint announces appointment of Justin Leushner as CEO and changes to the board of directors 223

6.59 Nov 01, 2019: First Optimizer Smart Device Implanted in China 224

6.60 Nov 01, 2019: Orthofix appoints Jon Serbousek as President and Chief Executive Officer 225

6.61 Oct 31, 2019: Impulse Device gets PMA approval from FDA for heart failure device 225

6.62 Oct 31, 2019: Surmodics reports fourth quarter fiscal 2019 results and issues fiscal 2020 revenue and EPS Guidance 226

6.63 Oct 30, 2019: LivaNova reports third quarter 2019 results 227

6.64 Oct 30, 2019: CONMED announces third quarter 2019 financial results 228

6.65 Oct 28, 2019: Philips delivers Q3 sales of EUR

4.7 billion, with 6% comparable sales growth, EUR 211 million income from continuing operations and an Adjusted EBITA margin of

12.4% 229

6.66 Oct 28, 2019: Philips' third quarter results 2019 231

6.67 Oct 28, 2019: Orthofix reports third quarter 2019 results 232

6.68 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 233

6.69 Oct 21, 2019: Sean Salmon named executive vice president and group president of Medtronic Diabetes 235

6.70 Oct 16, 2019: Orchestra BioMed strengthens management team with appointments of expert product development leaders Juan A. Lorenzo and Paul V. Goode, Ph.D. 236

6.71 Oct 10, 2019: Philips provides update on its financial performance in Q3 2019 237

6.72 Oct 07, 2019: Medtronic initiates worldwide pivotal study of a new approach to treating dangerously fast heart rhythms 238

6.73 Sep 23, 2019: CONMED adds LaVerne Council and Barbara Schwarzentraub to its Board of Directors 239

6.74 Sep 19, 2019: BioTrace Medical announces key events featuring Tempo Temporary Pacing Lead at TCT 2019 240

6.75 Sep 19, 2019: Ventripoint Diagnostics announces Justin Leushner as new President and Management Restructuring 241

7 Appendix 243

7.1 Methodology 243

7.2 About GlobalData 247

7.3 Contact Us 247

7.4 Disclaimer 247

List of Tables

Table 1: Cardiac Rhythm Management Devices – Pipeline Products by Stage of Development 16

Table 2: Cardiac Rhythm Management Devices – Pipeline Products by Segment 17

Table 3: Cardiac Rhythm Management Devices – Pipeline Products by Territory 18

Table 4: Cardiac Rhythm Management Devices – Pipeline Products by Regulatory Path 19

Table 5: Cardiac Rhythm Management Devices – Pipeline Products by Estimated Approval Date 20

Table 6: Cardiac Rhythm Management Devices – Ongoing Clinical Trials 21

Table 7: Cardiac Rhythm Management Devices Companies – Pipeline Products by Stage of Development 22

Table 8: Cardiac Rhythm Management Devices – Pipeline Products by Stage of Development 25

Table 9: A3 Remote Monitoring Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 28

Table 10: Wireless Device – Wearable Cardiac Rhythm Management System – Product Status 28

Table 11: Wireless Device – Wearable Cardiac Rhythm Management System – Product Description 28

Table 12: Advanced BioInformatics GmbH Pipeline Products & Ongoing Clinical Trials Overview 29

Table 13: Cardiac Rhythm Management Device – Product Status 29

Table 14: Cardiac Rhythm Management Device – Product Description 29

Table 15: AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview 30

Table 16: Guardian – Product Status 30

Table 17: Guardian – Product Description 30

Table 18: Angel Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 31

Table 19: Acute Ischemia Monitor – Product Status 31

Table 20: Acute Ischemia Monitor – Product Description 31

Table 21: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 32

Table 22: Wireless Pacemaker System – Product Status 32

Table 23: Wireless Pacemaker System – Product Description 32

Table 24: AtaCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 33

Table 25: AtaCor EV Temporary Pacing System – Product Status 33

Table 26: AtaCor EV Temporary Pacing System – Product Description 33

Table 27: AtaCor Medical Inc – Ongoing Clinical Trials Overview 34

Table 28: AtaCor EV Temporary Pacing System – AtaCor Subcostal Temporary Extravascular Pacing III Study 35

Table 29: AtaCor EV Temporary Pacing System – Subcostal Temporary Extracardiac Pacing II (STEP II) Study 35

Table 30: AtaCor EV Temporary Pacing System – Subcostal Temporary Extracardiac Pacing Study: Clinical Study of the AtaCor Extracardiac Pacing System 35

Table 31: Bionet Sonar Inc Pipeline Products & Ongoing Clinical Trials Overview 36

Table 32: Bi-Ventricular Pacing Device – Product Status 36

Table 33: Bi-Ventricular Pacing Device – Product Description 36

Table 34: Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview 37

Table 35: Renamic Neo – Product Status 37

Table 36: Renamic Neo – Product Description 37

Table 37: Biotronik SE & Co KG – Ongoing Clinical Trials Overview 38

Table 38: Renamic Neo – BIO|CONCEPT.Renamic Neo 39

Table 39: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 40

Table 40: EMBLEM MRI S-ICD System – Aged Patients – Product Status 41

Table 41: EMBLEM MRI S-ICD System – Aged Patients – Product Description 41

Table 42: EMPOWER Leadless Pacer – Product Status 41

Table 43: EMPOWER Leadless Pacer – Product Description 42

Table 44: INGENIO 2 PG – MICS – Product Status 42

Table 45: INGENIO 2 PG – MICS – Product Description 42

Table 46: Loop Recorder – Product Status 43

Table 47: Loop Recorder – Product Description 43

Table 48: MRI-Safe Implantable Cardiac Rhythm Management Lead – Product Status 43

Table 49: MRI-Safe Implantable Cardiac Rhythm Management Lead – Product Description 43

Table 50: Next Gen CRM PG – Product Status 44

Table 51: Next Gen CRM PG – Product Description 44

Table 52: Next Generation ICD Lead – Product Status 44

Table 53: Next Generation ICD Lead – Product Description 45

Table 54: Next Generation ICD/CRT-D – Product Status 45

Table 55: Next Generation ICD/CRT-D – Product Description 45

Table 56: Next Generation Quad Polar CRT-D – Product Status 46

Table 57: Next Generation Quad Polar CRT-D – Product Description 46

Table 58: NG3 Non Quad System – Product Status 46

Table 59: NG3 Non Quad System – Product Description 47

Table 60: Resonate 2.0 – Product Status 47

Table 61: Resonate 2.0 – Product Description 47

Table 62: S-ICD System 1.5 – Product Status 48

Table 63: S-ICD System 1.5 – Product Description 48

Table 64: S-ICD System 2.0 – Product Status 48

Table 65: S-ICD System 2.0 – Product Description 49

Table 66: Temporary RV VVI pacing – Product Status 49

Table 67: Temporary RV VVI pacing – Product Description 49

Table 68: VITALITY NXT Defibrillator – Product Status 50

Table 69: VITALITY NXT Defibrillator – Product Description 50

Table 70: X4 SYSTEM + QUAD LEAD – Product Status 50

Table 71: X4 SYSTEM + QUAD LEAD – Product Description 51

Table 72: Boston Scientific Corp – Ongoing Clinical Trials Overview 52

Table 73: Next Generation Quad Polar CRT-D – Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan 53

Table 74: EMBLEM MRI S-ICD System – Aged Patients – Multicenter Automatic Defibrillator Implantation Trial with Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD) 54

Table 75: Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview 55

Table 76: Raul Pacemaker – Product Status 55

Table 77: Raul Pacemaker – Product Description 55

Table 78: Cairdac Pipeline Products & Ongoing Clinical Trials Overview 56

Table 79: Leadless Cardiac Pacemaker – Product Status 56

Table 80: Leadless Cardiac Pacemaker – Product Description 56

Table 81: CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57

Table 82: MultiPulse Therapy Device – Product Status 57

Table 83: MultiPulse Therapy Device – Product Description 57

Table 84: CardiaLen, Inc. – Ongoing Clinical Trials Overview 58

Table 85: MultiPulse Therapy Device – A Clinical Feasibility Study to Evaluate the Safety and Performance of Low-energy Therapy in Patients with Atrial Fibrillation Energy Therapy in Patients with Atrial Fibrillation 59

Table 86: MultiPulse Therapy Device – An International Clinical Feasibility Study to Evaluate the Safety and Performance of Low-Energy Unpinning Termination Therapy in Patients with VT/VF 59

Table 87: Cardioalarm, Inc Pipeline Products & Ongoing Clinical Trials Overview 60

Table 88: CardioAlarm System – Product Status 60

Table 89: CardioAlarm System – Product Description 60

Table 90: Children’s National Health System Pipeline Products & Ongoing Clinical Trials Overview 61

Table 91: Delivery Tool – Epicardial Pacing And Defibrillation – Product Status 61

Table 92: Delivery Tool – Epicardial Pacing And Defibrillation – Product Description 61

Table 93: Corhythm Inc Pipeline Products & Ongoing Clinical Trials Overview 62

Table 94: Corhythm Implantable Device – Product Status 62

Table 95: Corhythm Implantable Device – Product Description 62

Table 96: Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview 63

Table 97: Table-Top PaDe System – Product Status 63

Table 98: Table-Top PaDe System – Product Description 63

Table 99: CVRx Inc Pipeline Products & Ongoing Clinical Trials Overview 64

Table 100: Barostim neo – Heart Failure – Product Status 64

Table 101: Barostim neo – Heart Failure – Product Description 64

Table 102: CVRx Inc – Ongoing Clinical Trials Overview 65

Table 103: Barostim neo – Heart Failure – Barostim HOPE4HF Study 66

Table 104: Barostim neo – Heart Failure – Barostim Neo – Baroreflex Activation Therapy for Heart Failure 66

Table 105: Barostim neo – Heart Failure – BAROSTIM THERAPY in Heart Failure With Preserved Ejection Fraction: A Post-Market Registry With the CE-Marked BAROSTIM NEO System 66

Table 106: Barostim neo – Heart Failure – BAROSTIM THERAPY in Heart Failure With Reduced Ejection Fraction: A Post-Market Registry with the BAROSTIM NEO System 67

Table 107: Barostim neo – Heart Failure – Barostim Therapy in Heart Failure with Reduced Ejection Fraction: A Post-market Registry with the CE-marked Barostim Neo System 67

Table 108: Barostim neo – Heart Failure – Health Outcomes Prospective Evaluation for Heart Failure with Ejection Fraction (EF) Greater than or Equal to 40% 68

Table 109: Barostim neo – Heart Failure – Investigation of the Efficacy and Safety of Baroreflex Activation Therapy in Patients with Refractory Hypertension and Those with Highly Variable Blood Pressure Due to Peripheral Baroreflex Failure 68

Table 110: DHS Medical Pipeline Products & Ongoing Clinical Trials Overview 69

Table 111: Drimmer – Product Status 69

Table 112: Drimmer – Product Description 69

Table 113: Twistek – Product Status 70

Table 114: Twistek – Product Description 70

Table 115: Drexel University Pipeline Products & Ongoing Clinical Trials Overview 71

Table 116: Conductance Controller Implant – Product Status 71

Table 117: Conductance Controller Implant – Product Description 71

Table 118: Duke University Pipeline Products & Ongoing Clinical Trials Overview 72

Table 119: Tissue-Engineered Autonomous Pacemaker – Product Status 72

Table 120: Tissue-Engineered Autonomous Pacemaker – Product Description 72

Table 121: EBR Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 73

Table 122: Second Generation WiSE CRT System – Product Status 73

Table 123: Second Generation WiSE CRT System – Product Description 73

Table 124: WiSE CRT System – Product Status 74

Table 125: WiSE CRT System – Product Description 74

Table 126: EBR Systems Inc – Ongoing Clinical Trials Overview 75

Table 127: WiSE CRT System – Image Optimization and Guidance for Wireless Endocardial Cardiac Resynchronization Therapy: The CT Guided Trial 76

Table 128: WiSE CRT System – Stimulation of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-responders and Previously Untreatable Patients: SOLVE CRT 76

Table 129: Endurance Rhythm Inc. Pipeline Products & Ongoing Clinical Trials Overview 77

Table 130: Endurance Rhythm Micro-Generator – Product Status 77

Table 131: Endurance Rhythm Micro-Generator – Product Description 77

Table 132: Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 78

Table 133: Aortic Pacemaker – Product Status 78

Table 134: Aortic Pacemaker – Product Description 78

Table 135: Impulse Dynamics NV Pipeline Products & Ongoing Clinical Trials Overview 79

Table 136: Optimizer IVs System – Product Status 79

Table 137: Optimizer IVs System – Product Description 79

Table 138: InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 80

Table 139: InnerPulse Pacemaker – Product Status 80

Table 140: InnerPulse Pacemaker – Product Description 80

Table 141: PICD – Product Status 81

Table 142: PICD – Product Description 81

Table 143: Integer Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 82

Table 144: Cardiomonix – Product Status 82

Table 145: Cardiomonix – Product Description 83

Table 146: IRadimed Corp Pipeline Products & Ongoing Clinical Trials Overview 84

Table 147: MR Defibrillator – Product Status 84

Table 148: MR Defibrillator – Product Description 84

Table 149: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 85

Table 150: Cardiac Arrhythmia Termination Device – Product Status 85

Table 151: Cardiac Arrhythmia Termination Device – Product Description 86

Table 152: Cardiac Sock Electrode And Implantable Defibrillator System – Product Status 86

Table 153: Cardiac Sock Electrode And Implantable Defibrillator System – Product Description 86

Table 154: PrestoPatch Integrated Electrode System – Product Status 87

Table 155: PrestoPatch Integrated Electrode System – Product Description 87

Table 156: QRSTee – Product Status 87

Table 157: QRSTee – Product Description 88

Table 158: Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview 89

Table 159: Unconditional MRI Compatible Implantable Defibrillator – Product Status 89

Table 160: Unconditional MRI Compatible Implantable Defibrillator – Product Description 89

Table 161: Unconditional MRI Compatible Implantable Pacemaker – Product Status 90

Table 162: Unconditional MRI Compatible Implantable Pacemaker – Product Description 90

Table 163: Kestra Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 91

Table 164: ASSURE Wearable Cardioverter Defibrillator – Product Status 91

Table 165: ASSURE Wearable Cardioverter Defibrillator – Product Description 91

Table 166: Krisara Engineering, LLC Pipeline Products & Ongoing Clinical Trials Overview 92

Table 167: Wireless Pacemaker – Product Status 92

Table 168: Wireless Pacemaker – Product Description 92

Table 169: Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 93

Table 170: Implantable Cardioverter Defibrillator – Ventricular Arrhythmias – Product Status 93

Table 171: Implantable Cardioverter Defibrillator – Ventricular Arrhythmias – Product Description 93

Table 172: Vagal Stimulation ICD Device – Product Status 94

Table 173: Vagal Stimulation ICD Device – Product Description 94

Table 174: Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview 95

Table 175: Implantable Defibrillator – Product Status 95

Table 176: Implantable Defibrillator – Product Description 95

Table 177: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 96

Table 178: Atrial Fibrillation Device – Product Status 96

Table 179: Atrial Fibrillation Device – Product Description 96

Table 180: Epicardial Pacing/sensing Lead – Product Status 97

Table 181: Epicardial Pacing/sensing Lead – Product Description 97

Table 182: Pacemaker/ICD Lead – Product Status 97

Table 183: Pacemaker/ICD Lead – Product Description 98

Table 184: Medicool Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 99

Table 185: Implantable Defibrillator – Product Status 99

Table 186: Implantable Defibrillator – Product Description 99

Table 187: Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 100

Table 188: Brady Wireless – Product Status 100

Table 189: Brady Wireless – Product Description 101

Table 190: Chronicle ICD – Product Status 101

Table 191: Chronicle ICD – Product Description 101

Table 192: EV-ICD System – Product Status 102

Table 193: EV-ICD System – Product Description 102

Table 194: Heart Pacemaker – Product Status 103

Table 195: Heart Pacemaker – Product Description 103

Table 196: LINQ II Insertable Cardiac Monitor – Product Status 103

Table 197: LINQ II Insertable Cardiac Monitor – Product Description 104

Table 198: Micra AR – Product Status 104

Table 199: Micra AR – Product Description 104

Table 200: Micra AV – Product Status 105

Table 201: Micra AV – Product Description 105

Table 202: Micra DDD Pacemaker – Product Status 105

Table 203: Micra DDD Pacemaker – Product Description 106

Table 204: MRI Safe CRT-D – Product Status 106

Table 205: MRI Safe CRT-D – Product Description 106

Table 206: Next Gen ICD And CRT-D – Product Status 107

Table 207: Next Gen ICD And CRT-D – Product Description 107

Table 208: Percepta Quad CRT-P MRI SureScan – Product Status 107

Table 209: Percepta Quad CRT-P MRI SureScan – Product Description 108

Table 210: Medtronic Plc – Ongoing Clinical Trials Overview 109

Table 211: EV-ICD System – Extravascular ICD Pilot Study 110

Table 212: EV-ICD System – Extravascular ICD Pivotal Study: EV ICD 110

Table 213: LINQ II Insertable Cardiac Monitor – Obstructive Sleep Apnoea and Cardiac Arrhythmias and the Impact of an Implantable Loop Recorder 111

Table 214: Percepta Quad CRT-P MRI SureScan – Optimizing Pacemaker Therapy Using Multi-point Pacing: The OPT-MPP Study 112

Table 215: MicroPort CRM Pipeline Products & Ongoing Clinical Trials Overview 113

Table 216: ALIZEA Pacemaker – Product Status 113

Table 217: ALIZEA Pacemaker – Product Description 113

Table 218: BonaFire – Active Pacing Lead – Product Status 114

Table 219: BonaFire – Active Pacing Lead – Product Description 114

Table 220: BonaFire – Passive Pacing Lead – Product Status 114

Table 221: BonaFire – Passive Pacing Lead – Product Description 115

Table 222: Nano Lead System – Product Status 115

Table 223: Nano Lead System – Product Description 115

Table 224: NAVIGO 4LV 2D – Product Status 116

Table 225: NAVIGO 4LV 2D – Product Description 116

Table 226: NAVIGO 4LV ARC – Product Status 116

Table 227: NAVIGO 4LV ARC – Product Description 117

Table 228: NAVIGO 4LV PILOT – Product Status 117

Table 229: NAVIGO 4LV PILOT – Product Description 117

Table 230: PARADYM RF SonR CRT-D – Product Status 118

Table 231: PARADYM RF SonR CRT-D – Product Description 118

Table 232: Reply MRI Pacemaker – Product Status 118

Table 233: Reply MRI Pacemaker – Product Description 119

Table 234: SonR Tist Lead Positioning – Product Status 119

Table 235: SonR Tist Lead Positioning – Product Description 119

Table 236: SonRFix Lead – Product Status 120

Table 237: SonRFix Lead – Product Description 120

Table 238: Tachy Lead – Product Status 120

Table 239: Tachy Lead – Product Description 121

Table 240: Triple-Site Ventricular (Tri-V) Pacing CRT-D – Product Status 121

Table 241: Triple-Site Ventricular (Tri-V) Pacing CRT-D – Product Description 121

Table 242: TX Brady Lead – Product Status 122

Table 243: TX Brady Lead – Product Description 122

Table 244: MicroPort CRM – Ongoing Clinical Trials Overview 123

Table 245: NAVIGO 4LV 2D – Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector 124

Table 246: NAVIGO 4LV ARC – Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector 125

Table 247: NAVIGO 4LV PILOT – Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector 126

Table 248: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 127

Table 249: Implantable Pulse Generator – Product Status 127

Table 250: Implantable Pulse Generator – Product Description 127

Table 251: Invicta Defibrillation Lead – Product Status 128

Table 252: Invicta Defibrillation Lead – Product Description 128

Table 253: TPG – External Temporary Pacemaker – Product Status 128

Table 254: TPG – External Temporary Pacemaker – Product Description 128

Table 255: MicroPort Scientific Corp – Ongoing Clinical Trials Overview 129

Table 256: Invicta Defibrillation Lead – Safety and Electrical Performance Evaluation of INVICTA Leads Models Equipped with DF4 Connector 130

Table 257: NanoLinea Pipeline Products & Ongoing Clinical Trials Overview 131

Table 258: CardioLinea – Product Status 131

Table 259: CardioLinea – Product Description 131

Table 260: NewPace Ltd Pipeline Products & Ongoing Clinical Trials Overview 132

Table 261: The Implantable Subcutaneous String Defibrillator (ISSD) – Product Status 132

Table 262: The Implantable Subcutaneous String Defibrillator (ISSD) – Product Description 132

Table 263: NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 133

Table 264: Biological Pacemaker – Product Status 133

Table 265: Biological Pacemaker – Product Description 133

Table 266: Odem Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 134

Table 267: Epicardial Lead Delivery Tool – Product Status 134

Table 268: Epicardial Lead Delivery Tool – Product Description 134

Table 269: Odem Device – Product Status 135

Table 270: Odem Device – Product Description 135

Table 271: Pericardial Access Device – Product Status 135

Table 272: Pericardial Access Device – Product Description 135

Table 273: Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 136

Table 274: Chronicle – Product Status 136

Table 275: Chronicle – Product Description 136

Table 276: Osypka Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 137

Table 277: PACE 300 – Product Status 137

Table 278: PACE 300 – Product Description 138

Table 279: Perpetuum Ltd Pipeline Products & Ongoing Clinical Trials Overview 139

Table 280: Implantable Self-Energising Pacemaker – Product Status 139

Table 281: Implantable Self-Energising Pacemaker – Product Description 139

Table 282: Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview 140

Table 283: Non-Invasive Device – Abnormal Heart Rhythm – Product Status 140

Table 284: Non-Invasive Device – Abnormal Heart Rhythm – Product Description 140

Table 285: Rice University Pipeline Products & Ongoing Clinical Trials Overview 141

Table 286: Battery-Less Pacemaker – Product Status 141

Table 287: Battery-Less Pacemaker – Product Description 141

Table 288: Second-Chance AED Pads – Product Status 142

Table 289: Second-Chance AED Pads – Product Description 142

Table 290: Shaanxi Qinming Medical Instruments Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 143

Table 291: QM7211 Electrode – Product Status 143

Table 292: QM7211 Electrode – Product Description 143

Table 293: Smartwave Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 144

Table 294: Fully Automatic Implantable Atrial Defibrillator – Product Status 144

Table 295: Fully Automatic Implantable Atrial Defibrillator – Product Description 144

Table 296: Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview 145

Table 297: Next Gen Lead Management (LM) Tool – Product Status 145

Table 298: Next Gen Lead Management (LM) Tool – Product Description 145

Table 299: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 146

Table 300: Quartet NXT – Double Blend Lead – Product Status 146

Table 301: Quartet NXT – Double Blend Lead – Product Description 147

Table 302: Quartet NXT – Large S-Curve Lead – Product Status 147

Table 303: Quartet NXT – Large S-Curve Lead – Product Description 148

Table 304: Quartet NXT – Small S-Curve Lead – Product Status 148

Table 305: Quartet NXT – Small S-Curve Lead – Product Description 149

Table 306: SUNY Downstate Medical Center Pipeline Products & Ongoing Clinical Trials Overview 150

Table 307: Vagus Nerve Stimulator – Ventricular Arrhythmia – Product Status 150

Table 308: Vagus Nerve Stimulator – Ventricular Arrhythmia – Product Description 150

Table 309: Suzhou Wushuang Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 151

Table 310: Implantable Cardioverter Defibrillator – Product Status 151

Table 311: Implantable Cardioverter Defibrillator – Product Description 151

Table 312: Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 152

Table 313: Pacemaker Lead – Product Status 152

Table 314: Pacemaker Lead – Product Description 152

Table 315: Thayer School of Engineering at Dartmouth Pipeline Products & Ongoing Clinical Trials Overview 153

Table 316: Self-Charging Pacemaker – Product Status 153

Table 317: Self-Charging Pacemaker – Product Description 153

Table 318: U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview 154

Table 319: BioPace – Product Status 154

Table 320: BioPace – Product Description 154

Table 321: University of Bern Pipeline Products & Ongoing Clinical Trials Overview 155

Table 322: Batteryless Cardiac Pacemaker – Product Status 155

Table 323: Batteryless Cardiac Pacemaker – Product Description 155

Table 324: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 156

Table 325: Cardiac Disease Monitoring Device – Product Status 156

Table 326: Cardiac Disease Monitoring Device – Product Description 156

Table 327: Intravascular Wirelessly Powered Micro-Pacer – Product Status 157

Table 328: Intravascular Wirelessly Powered Micro-Pacer – Product Description 157

Table 329: University of Glasgow Pipeline Products & Ongoing Clinical Trials Overview 158

Table 330: Implantable Cardiac Monitor – Product Status 158

Table 331: Implantable Cardiac Monitor – Product Description 158

Table 332: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 159

Table 333: Cardiac Energy Harvesting Pacemaker – Product Status 159

Table 334: Cardiac Energy Harvesting Pacemaker – Product Description 159

Table 335: University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 160

Table 336: Fetal Micro-Pacemaker – Product Status 160

Table 337: Fetal Micro-Pacemaker – Product Description 160

Table 338: Micropacemaker – Product Status 161

Table 339: Micropacemaker – Product Description 161

Table 340: University of Utah Pipeline Products & Ongoing Clinical Trials Overview 162

Table 341: Blood Pressure Response Algorithm – Product Status 162

Table 342: Blood Pressure Response Algorithm – Product Description 162

Table 343: Glossary 246

List of Figures

Figure 1: Cardiac Rhythm Management Devices – Pipeline Products by Stage of Development 16

Figure 2: Cardiac Rhythm Management Devices – Pipeline Products by Segment 17

Figure 3: Cardiac Rhythm Management Devices – Pipeline Products by Territory 18

Figure 4: Cardiac Rhythm Management Devices – Pipeline Products by Regulatory Path 19

Figure 5: Cardiac Rhythm Management Devices – Pipeline Products by Estimated Approval Date 20

Figure 6: Cardiac Rhythm Management Devices – Ongoing Clinical Trials 21

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports